Tovecimig-Based Doublet Boosts Response and PFS in Advanced Biliary Tract Cancer
Tovecimig-Based Doublet Boosts Response and PFS in Advanced Biliary Tract Cancer MedPage Today
Tovecimig-Based Doublet Boosts Response and PFS in Advanced Biliary Tract Cancer MedPage Today
Laure-Anne Teuwen։ Bishal Gyawali Shares an Important Message on Reading and Interpreting Cancer Clinical Trials at ESMO 2026 Oncodaily
Maria Maddalena Laterza: Biomarkers in Gastroesophageal Cancer - Challenges and Hope at ESMO 2026 Oncodaily
Is Active Surveillance Feasible for Esophageal Cancer? Medscape
ESMO26: Lily's sofe-m ADC stakes a claim in ovarian cancer pharmaphorum
Amgen drug combined with immunotherapy extends survival in lung cancer trial Reuters
Невиданный ранее прорыв в онкологии: иммунная система научилась распознавать угрозы организма Правда.Ру
Lung cancer breakthrough: drug combination cuts death risk by 58% in major trial Ynetnews
Стыдный симптом у школьницы перерос в 25-летнюю войну с раком Новости Zakon.kz
Individualized Cancer Vaccine Shows Encouraging Results for Patients at High Risk for Recurrence AIM at Melanoma Foundation
DASL-HiCaP at ESMO 2026: Darolutamide Plus ADT and Radiotherapy in Very High-Risk Prostate Cancer Oncodaily
Doctors explain why breast cancer screening should start at age 40 News-Medical
Felicia Flowitt: Redefining the Future of Cancer Care Ahead of ESMO 2026 Oncodaily
У 57-летней женщины обнаружили рак желудка на ранней стадии, основываясь на симптомах, которые многие вьетнамцы упускают из виду. Vietnam.vn